Compare Decibel Cannabis Co., Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 66 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.77
-28.22%
1.10
Revenue and Profits:
Net Sales:
30 Million
(Quarterly Results - Mar 2026)
Net Profit:
-2 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.35%
0%
4.35%
6 Months
9.09%
0%
9.09%
1 Year
60.0%
0%
60.0%
2 Years
84.62%
0%
84.62%
3 Years
-7.69%
0%
-7.69%
4 Years
20.0%
0%
20.0%
5 Years
-65.22%
0%
-65.22%
Decibel Cannabis Co., Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
26.45%
EBIT Growth (5y)
-41.06%
EBIT to Interest (avg)
-4.22
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.56
Sales to Capital Employed (avg)
1.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0.27%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.10
EV to EBIT
-7.84
EV to EBITDA
-14.51
EV to Capital Employed
1.06
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.48%
ROE (Latest)
-28.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
29.80
21.20
40.57%
Operating Profit (PBDIT) excl Other Income
-0.00
-3.10
100.00%
Interest
1.00
0.70
42.86%
Exceptional Items
0.50
4.00
-87.50%
Consolidate Net Profit
-2.20
-1.90
-15.79%
Operating Profit Margin (Excl OI)
-55.60%
-221.50%
16.59%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 40.57% vs 0.95% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -15.79% vs -1,050.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
112.70
92.50
21.84%
Operating Profit (PBDIT) excl Other Income
-10.80
-3.70
-191.89%
Interest
2.70
2.90
-6.90%
Exceptional Items
17.30
10.70
61.68%
Consolidate Net Profit
-2.90
13.60
-121.32%
Operating Profit Margin (Excl OI)
-154.50%
-93.90%
-6.06%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 21.84% vs -12.90% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -121.32% vs 815.79% in Dec 2024
About Decibel Cannabis Co., Inc. 
Decibel Cannabis Co., Inc.
Pharmaceuticals & Biotechnology
Decibel Cannabis Company Inc., formerly Westleaf Inc, is a Canada-based vertically integrated cannabis company. The Company has assets across the cannabis value chain, with an emphasis on engaging cannabis retail and product brands. The Company invests in building its manufacturing facilities. It is an owner of several brands, such as Qwest, Prairie Records and BlendCraft. Prairie Records is a retail concept that merges recreational cannabis and music. The Qwest brand provides Wonder Qwest, Zest Qwest, Vision Qwest, Ice Qwest and Spirit Qwest. BlendCraft is created using only flower and trichome-coated sugar leaf from Qwest’s collection of cultivars.
Company Coordinates 
Company Details
1000, 517-10Th Avenue Sw , CALGARY AB : T2R 0A8
Registrar Details






